1. Value in Health Regional Issues
A Cost-Utility Analysis Comparing Standard Axillary Lymph Node Dissection with Sentinel Lymph Node Biopsy in Patients with Early Stage Breast Cancer in Thailand 
Dolrudee Songtish, MD, Msc, Naiyana Praditsitthikorn, BSc, PhD, Yot Teerawattananon, MD, PhD 
Value in Health Regional Issues 
Volume 3, Pages (May 2014)
DOI: /j.vhri
Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

2. Fig. 1
Decision tree. ALND, axillary lymph node biopsy; LR, local recurrence; RR regional recurrence; SNB, sentinel lymph node biopsy.
Value in Health Regional Issues 2014 3, 59-66DOI: ( /j.vhri )
Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

3. Fig. 2
The percentage change in ICER compared with the mean ICER for each parameter. Mean ICER = −470, THB/QALY gained. ALND, axillary lymph node dissection; BCT, breast-conserving therapy; ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life year; SNB, sentinel lymph node biopsy; THB, Thai baht.
Value in Health Regional Issues 2014 3, 59-66DOI: ( /j.vhri )
Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

4. Fig. 3
Cost-effectiveness acceptability curve. ALND, axillary lymph node dissection; QALY, quality-adjusted life-year; SNB, sentinel lymph node biopsy.
Value in Health Regional Issues 2014 3, 59-66DOI: ( /j.vhri )
Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions